Michael B. Hoffman, Director at Annovis Bio, Inc. (ANVS), bought 67,296 shares at $4.15 ($276K) on 2025-11-24, disclosed to the SEC on 2025-11-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.85 | 9,200 | $35K | 12.8% |
| 2 | $4.13 | 1,489 | $6K | 2.2% |
| 3 | $4.14 | 415 | $2K | 0.6% |
| 4 | $4.15 | 28,096 | $117K | 42.2% |
| 5 | $4.15 | 28,096 | $117K | 42.2% |
| Total | $4.11 avg | 67,296 |
| $276K |
| 100% |
| Filing → |
| ANVS | BUY | 2025-12-08 | $194K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |
| ANVS | BUY | 2025-11-18 | $32K | — | Filing → |